Summary

Eligibility
for males ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by David Bayne, MD, MPH
Headshot of David Bayne
David Bayne

Description

Summary

This will be a randomized interventional study. Patients scheduled to undergo a HoLEP at UCSF will be randomized into two groups after the procedure: one group will watch a scripted educational HoLEP video and the other group will not receive a video. We will monitor the post-operative care utilization after discharge. Secondary outcomes will include patient satisfaction.

Official Title

The Impact of Discharge Educational Discharge Videos on Post-Operative Care Utilization After Holmium Laser Enucleation of the Prostate (HoLEP) Procedures

Keywords

HoLEP, Patient Satisfaction, Educational Video Intervention, Video

Eligibility

You can join if…

Open to males ages 18 years and up

  1. Adults aged 18+
  2. Patients scheduled for a HoLEP procedure
  3. Patients willing to complete both baseline and follow up surveys
  4. Patients able to provide informed consent
  5. Patients are English-speaking and understand English

You CAN'T join if...

  1. Patients under 18+
  2. Patients unable to consent
  3. Patients unable to complete surveys
  4. Patients without a prostate.
  5. Patients are non-English speakers

Locations

  • UCSF
    San Francisco California 94143 United States
  • University of Rochester Medical Center
    Rochester New York 14620 United States
  • Scott SUNY Upstate Medical University
    Syracuse New York 13210 United States

Lead Scientist at UCSF

  • David Bayne, MD, MPH
    Co-Director of the UCSF Center for Health Equity in Surgery and Anesthesia Director of Simulation Education Dr. David Bayne, MD, MPH studies the clinical, social and behavioral factors that contribute to kidney stone formation and influence treatment outcomes as UCSF Urology faculty.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06975033
Study Type
Interventional
Participants
Expecting 114 study participants
Last Updated